PharmaCyte Biotech PMCB Balance Sheet (2009-2026)

NASDAQ PMCB
$0.39 -0.01 (-1.63%)
As of: Nov 12, 2026 · 10:14 AM EST
Reported Financials

PharmaCyte Biotech Quarterly Balance Sheet

Periods 71 quarters
Latest Jul 2026

PharmaCyte Biotech reported total assets of $36.71M and total liabilities of $9.20M for the quarter ended Jul 2026, down 18.6% year over year. This balance sheet covers 71 quarters of results from Jan 2009 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Jan2009 Apr2009 Jul2009 Oct2009 Jan2010 Apr2010 Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026 Jul2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
86.94M86.64M85.40M82.23M76.96M72.64M68.04M74.66M73.43M61.21M50.18M32.64M20.84M16.38M15.17M13.18M15.41M20.17M18.60M17.74M
Short-term InvestmentsInvestments (Current)
0.37M0.37M0.26M0.20M0.37M0.25M0.10M
Cash & Current Investments
86.94M86.64M85.40M82.23M76.96M72.64M68.04M74.66M73.43M61.21M50.18M32.64M20.84M16.76M15.54M13.44M15.61M20.54M18.86M17.84M
Receivables - NetNet Receivables
2.76M3.36M0.24M0.43M
Receivables - OtherOther Receivables
Receivables
2.76M3.36M0.24M0.43M
Inventory
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
0.24M0.17M0.09M0.03M0.26M0.18M0.11M0.09M0.32M0.30M0.26M0.24M0.49M0.21M0.22M0.24M0.50M0.16M0.10M0.03M
Current Assets
87.18M86.81M85.49M82.26M77.22M72.82M68.15M74.75M73.75M61.51M50.44M32.88M21.33M16.96M22.38M19.11M23.02M20.70M37.42M30.97M
Non-Current Assets
Buildings
Property, Plant & Equipment (Net)PP&E (Net)
Long-Term Investments
1.57M1.57M1.57M1.57M1.57M1.57M1.57M1.57M1.57M1.57M29.12M24.86M18.63M22.47M19.64M20.75M22.47M9.37M
Goodwill
Intangibles
3.55M3.55M3.55M3.55M3.55M3.55M3.55M3.55M3.55M3.55M1.55M1.55M1.55M1.55M1.55M1.55M1.55M1.55M
Goodwill & Intangibles
3.55M3.55M3.55M3.55M3.55M3.55M3.55M3.55M3.55M3.55M1.55M1.55M1.55M1.55M1.55M1.55M1.55M1.55M
Long-Term Deferred Tax
Other Non-Current Assets
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Non-Current Assets
5.13M5.13M5.13M5.13M5.13M5.13M5.13M5.13M5.13M9.85M9.46M37.32M33.77M26.87M32.79M26.00M32.95M35.18M9.33M5.74M
Assets
92.31M91.94M90.62M87.39M82.35M77.95M73.28M79.88M78.88M71.36M59.90M70.19M55.10M43.83M55.17M45.11M55.98M55.87M46.75M36.71M
Liabilities
Current Liabilities
Accounts Payables
0.16M0.09M0.21M0.56M0.86M0.45M0.13M0.72M0.13M0.48M0.74M0.55M0.35M0.48M0.40M0.47M1.02M1.20M0.27M0.39M
Notes Payables
Dividends payables
0.32M4.10M6.28M6.30M6.23M3.72M0.04M0.03M0.03M0.03M
Payables
0.16M0.09M0.21M0.56M0.86M0.45M0.13M1.04M4.22M6.76M7.03M6.79M4.07M0.48M0.40M0.47M1.06M1.23M0.30M0.42M
Accumulated Expenses
0.03M0.52M0.50M0.53M0.45M0.38M0.46M0.48M1.02M0.77M0.74M0.68M0.71M0.71M5.06M0.60M0.52M0.45M0.52M0.35M
Other Accumulated Expenses
0.47M0.38M0.38M0.38M0.29M0.29M0.29M0.44M0.39M
Short term Debt
Current Taxes
Current Deferred Revenue
Total Current Liabilities
0.19M0.61M0.70M1.09M1.31M0.83M0.59M1.52M5.24M7.54M7.42M7.47M4.78M1.19M2.91M1.06M1.58M1.68M0.83M0.77M
Non-Current Liabilities
Non-Current Debt
Convertible Debt
Preferred Stock Liabilities
0.00M16.75M21.30M17.52M11.87M5.33M0.00M0.00M0.00M0.00M0.90M0.87M1.27M1.89M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Other Non-Current Liabilities
18.88M15.57M14.93M12.97M9.68M6.87M2.38M0.36M0.46M17.85M14.79M10.95M6.13M
Total Non-Current Liabilities
0.59M21.81M26.54M25.06M19.29M12.81M4.78M1.19M2.91M1.06M2.90M2.97M2.51M3.08M
Total Liabilities
0.19M0.61M0.70M1.09M1.31M0.83M0.59M40.69M42.11M39.98M32.26M22.49M11.65M3.58M3.28M1.52M20.74M17.76M13.46M9.20M
Shareholder's Equity
Total Debt
Common Equity
92.12M91.33M89.92M86.30M81.04M77.12M72.69M39.19M36.77M31.37M27.65M47.71M43.45M40.25M51.89M43.59M35.24M38.11M33.29M27.51M
Liabilities and Shareholders Equity
92.31M91.94M90.62M87.39M82.35M77.95M73.28M79.88M78.88M71.36M59.90M70.19M55.10M43.83M55.17M45.11M55.98M55.87M46.75M36.71M
Treasury Stock
2.09M5.48M9.25M13.56M40.02M40.45M40.85M42.04M42.79M44.21M44.43M44.61M44.61M44.61M45.01M45.01M45.01M
Retained Earnings
-109.41M-110.23M-111.65M-113.19M-115.07M-115.84M-115.96M-119.14M-116.35M-116.97M-115.63M-92.20M-93.67M-96.72M-84.97M-93.33M-100.75M-100.00M-104.39M-109.47M
Preferred Shares
20.03M
Treasury Shares
0.85M2.08M3.39M4.81M12.89M12.97M13.15M13.63M13.95M14.64M14.77M14.88M14.88M14.88M15.27M15.27M15.27M

PharmaCyte Biotech Balance Sheet API

Pull PharmaCyte Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PMCB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY